Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof | Patent Publication Number 20190382481

US 20190382481 A1
Patent NumberUS 11466082 B2
Application Number16418420
Filled DateMay 21, 2019
Priority DateMay 24, 2018
Publication DateDec 19, 2019
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsRonan McDaid
Priyanka Nair-Gupta
Michael Diem
Francois Gaudet
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.